-$0.31 Earnings Per Share Expected for Health Catalyst (NASDAQ:HCAT) This Quarter

Analysts expect Health Catalyst (NASDAQ:HCAT) to report earnings per share (EPS) of ($0.31) for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Health Catalyst’s earnings. The lowest EPS estimate is ($0.33) and the highest is ($0.28). The firm is scheduled to announce its next quarterly earnings results on Tuesday, February 11th.

According to Zacks, analysts expect that Health Catalyst will report full year earnings of ($1.13) per share for the current fiscal year, with EPS estimates ranging from ($1.23) to ($1.02). For the next year, analysts expect that the business will post earnings of ($0.97) per share, with EPS estimates ranging from ($1.04) to ($0.86). Zacks’ EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Health Catalyst.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Tuesday, November 12th. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.37) by $0.10. The firm had revenue of $39.40 million during the quarter, compared to analysts’ expectations of $37.77 million. The business’s revenue was up 19.8% compared to the same quarter last year.

HCAT has been the subject of several analyst reports. Evercore ISI initiated coverage on shares of Health Catalyst in a research note on Monday, August 19th. They issued an “outperform” rating and a $50.00 target price for the company. Leerink Swann initiated coverage on shares of Health Catalyst in a research note on Monday, August 19th. They issued an “outperform” rating and a $55.00 target price for the company. Piper Jaffray Companies initiated coverage on shares of Health Catalyst in a research note on Monday, August 19th. They issued an “overweight” rating and a $47.00 target price for the company. Zacks Investment Research downgraded shares of Health Catalyst from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, Goldman Sachs Group assumed coverage on shares of Health Catalyst in a research note on Monday, August 19th. They issued a “buy” rating and a $49.00 target price for the company. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $50.22.

Shares of HCAT stock traded down $0.82 on Friday, hitting $33.44. The stock had a trading volume of 191,365 shares, compared to its average volume of 183,538. The business has a 50 day simple moving average of $35.52. The company has a current ratio of 5.27, a quick ratio of 5.27 and a debt-to-equity ratio of 0.24. Health Catalyst has a 52-week low of $26.00 and a 52-week high of $49.85.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Metropolitan Life Insurance Co NY bought a new position in Health Catalyst during the 3rd quarter valued at $161,000. Millennium Management LLC acquired a new position in shares of Health Catalyst in the 3rd quarter valued at about $735,000. Orbimed Advisors LLC bought a new stake in shares of Health Catalyst during the 3rd quarter valued at about $5,682,000. California State Teachers Retirement System bought a new stake in shares of Health Catalyst during the 3rd quarter valued at about $400,000. Finally, State Street Corp acquired a new stake in Health Catalyst during the third quarter worth about $4,119,000. Hedge funds and other institutional investors own 45.63% of the company’s stock.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Read More: What are the economic characteristics of a bear market?

Get a free copy of the Zacks research report on Health Catalyst (HCAT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.